METHYLATION BIOMARKERS FOR DIAGNOSIS AND RISK STRATIFICATION OF PROSTATE CANCER

$171,347FY2009Department of the ArmyDOD

Mayo Clinic, Rochester MN

Investigators

METHYLATION BIOMARKERS FOR DIAGNOSIS AND RISK STRATIFICATION OF PROSTATE CANCER · GrantIndex